FDA invites you to the Generic Drugs Forum 2026
The U.S. Food and Drug Administration (FDA) will host its annual Generic Drugs Forum (GDF) on April 22 and 23, 2026. The two-day forum aims to promote the development and approval of safe, effective, and high-quality generic drugs. It is geared toward current and potential applicants for simplified drug approval (ANDA) procedures. The event brings together FDA professionals from all areas of the pre-ANDA and ANDA evaluation programs. Attendees will gain practical insights and guidance on regulatory requirements. The goal is to improve the quality of applications, streamline the review process, and reduce the number of review rounds, thereby enabling faster access to affordable medicines for patients. "This forum will help applicants submit complete and high-quality documentation," the FDA announcement states. A faster and more efficient approval process ultimately contributes to public health by ensuring the availability of affordable alternatives to brand-name drugs. The Generic Drugs Forum will take place both in person…






